1 |
Abouwarda AM, Ismail TA, Abu El-Wafa WM, Faraag AHI. Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori. World J Microbiol Biotechnol 2022;38:102. [PMID: 35486219 DOI: 10.1007/s11274-022-03289-2] [Reference Citation Analysis]
|
2 |
Bagheri N, Sadeghiani M, Rahimian G, Mahsa M, Shafigh M, Rafieian-kopaei M, Shirzad H. Correlation between expression of MMP-9 and MMP-3 in Helicobacter pylori infected patients with different gastroduodenal diseases. Arab Journal of Gastroenterology 2018;19:148-54. [DOI: 10.1016/j.ajg.2018.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
3 |
Diab M, Shemis M, Gamal D, El-shenawy A, El-ghannam M, El-sherbini E, Saber M. Helicobacter pylori Western cagA genotype in Egyptian patients with upper gastrointestinal disease. Egyptian Journal of Medical Human Genetics 2018;19:297-300. [DOI: 10.1016/j.ejmhg.2018.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
4 |
Al-Eraky DM, Helmy OM, Ragab YM, Abdul-Khalek Z, El-Seidi EA, Ramadan MA. Prevalence of CagA and antimicrobial sensitivity of H. pylori isolates of patients with gastric cancer in Egypt. Infect Agent Cancer. 2018;13:24. [PMID: 30026792 DOI: 10.1186/s13027-018-0198-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
5 |
Hassan RM, Ghaith DM, Ismail DK, Zafer MM. Reduced susceptibility of Enterococcus spp. isolates from Cairo University Hospital to tigecycline: Highlight on the influence of proton pump inhibitors. Journal of Global Antimicrobial Resistance 2018;12:68-72. [DOI: 10.1016/j.jgar.2017.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|